Trends in Exploitation of Packed Red Blood Cells

References

• Bishop C. Assay for hexokinase activity in intact red cells and its alteration on storage. J. Biol. Chem. 1964; 239: 1053–1056
   PubMedGoogle Scholar
• Pristoupilova K., Pristoupil T. I. Oxidative trans-methylation: A proposed metabolic cycle involving folates, vitamin B12 and S-adenosylmethionine. Specul. Sci. Technol., Life Sci. Ed. 1987, in press
   Google Scholar
• Pristoupil T. I., Kramlova M., Fortova H., Ulrych S. Haemoglobin lyophilized with sucrose: The effect of residual moisture on storage. Haematologia 1985; 18: 45–52
   PubMedGoogle Scholar
• Goldstein J. Preparation of transfusable red cells by enzymic conversion. In The Red Cell: Sixth Ann Arbor Conference. A.R. Liss, New York 1984; 139–157
   Google Scholar
• Labrude P., Loppinet V., Vigneron C. Molecules protectrices au cours de la lyophilisation de l'hemoglobine. Ann. pharm. franc. 1976; 34: 143–149
   PubMedGoogle Scholar
• Vigneron C., Labrude P., Moser P., Dellacherie E. Les transporteurs d'oxygene en transfusion: choix possibles. Bull. Soc. Chim. Franc. 1985; 4: 555–561
   Google Scholar
• Bolin R. B., Geyer R. P., Nemo C. J. Advances in Blood Substitutes Research, Progress in Clin. Biol. Res. 1983; 122: 1–149
   PubMedGoogle Scholar
• Chang T. M.S. 3rd International Symposium on Blood Substitutes, Montreal, May 26–28, 1987, Symposium chairman
   Google Scholar
• Kramlova M., Pristoupil T. I., Fricova V., Kraml J. First experience with the use of the Pharmacia PhastSystem for the characterization of hemoglobins by isoelectric focusing. J. Chromatogr. 1986; 367: 443–445
   PubMed Web of Science ®Google Scholar
• Fricova V., Pristoupil T. I., Kramlova M., Pasluska E. Human Hemoglobin modified by pyridoxalphosphate and glutaraldehyde in the presence of serum albumin. I. Preparation and chemical properties of a new variant of infusable solution. Biologia 1986; 41: 697–704
   Google Scholar
• Pristoupil T. I., Kramlova M., Fortova H., Fricova V., Kadlecova L. Characterization of hemoglobinous blood substitutes by chromatography and isoelectric focusing with stabilized oxyhemoglobin as a pI marker. J. Chromatogr. 1984; 288: 469–473
   PubMedGoogle Scholar
• Pristoupil T. I., Kramlova M., Fricova V., Kraml J. Comparative chromatography of fresh, freeze-dried and chemically modified human hemoglobin on the cation exchanger Mono S.J. J. Chromatogr. 1986; 368: 459–461
   Google Scholar
• Fricova V., Paluska E., Pristoupil T. I., Kramlova M. Human hemoglobin modified by pyridoxalphosphate and glutaraldehyde in the presence of serum albumin. II. Model experiments of exchange transfusion on rats. Biologia 1986; 41: 1079–1084
   Google Scholar
• Pristoupil T. I., Kramlova M., Fricova V., Mosinger B. Haemoglobin solutions: Reversibly bound oxygen and its effect upon the hypoxic heart. Physiol. Bohemoslov. 1986; 35: 193–198
   PubMedGoogle Scholar
• Pristoupil J. Cinatl, Ulrych T. I. S., Kramlova M., Polednova V. Testing of hemoglobin infusion solution on the human “LEP” cells in a through-flow cultivating system in vitro. Ceskoslov. Farm. 1981; 30: 57–60
   PubMedGoogle Scholar
• Dudziak R., Bonhard K. The development of hemoglobin preparations for various indications. Anaesthesist 1980; 29: 181–189
   PubMed Web of Science ®Google Scholar
• Elert O., Kunkel B., Lang J. Vergleichende Untersuchungen zur Myokardprotektion mit Nif edipin und Magnesium-Aspartat-Procain und Kaliumchlorid in Verbindung mit Sauerstofftraegern. Calciumantagonisten zur Kardioplegie und Myokardprotektion in der offenen Herzchirurgie, H. Just, A. Tschirkov, V. Schlosser. G. Thiem, Stuttgart 1982; 134–140
   Google Scholar
• Vrana M., Pristoupil T. I., Klika T., Havlockova J., Vranova Z., Kocandrle V. Experimental cardioplegia using stroma-free hemoglobin. Cor Vasa 1987, in press
   Google Scholar
• Hearse D. J., Erol C., Robinson L. A., Maxwell M. P., Baimbridge M. V. Particle-induced coronary vaso-constriction during cardioplegic infusion. J. Thorac. Cardiovasc. Surg. 1985; 89: 428–438
   PubMed Web of Science ®Google Scholar